Hikma Pharmaceuticals Plc. (HKMPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 455,000 | 281,000 | 233,000 | 544,000 | 558,000 |
| Depreciation Amortization | N/A | N/A | 359,000 | 133,000 | 79,000 |
| Accounts receivable | -144,000 | -24,000 | 4,000 | -166,000 | -47,000 |
| Accounts payable and accrued liabilities | 78,000 | 88,000 | 16,000 | 14,000 | 6,000 |
| Other Working Capital | -135,000 | 80,000 | -131,000 | -28,000 | -208,000 |
| Other Operating Activity | 310,000 | 183,000 | 49,000 | 141,000 | 76,000 |
| Operating Cash Flow | $564,000 | $608,000 | $530,000 | $638,000 | $464,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,000 | -49,000 | -15,000 | -2,000 | -6,000 |
| PPE Investments | -165,000 | -151,000 | -137,000 | -145,000 | -172,000 |
| Net Acquisitions | -140,000 | -98,000 | -374,000 | 3,000 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 5,000 | N/A |
| Purchase Sale Intangibles | -70,000 | -35,000 | -78,000 | -84,000 | -52,000 |
| Other Investing Activity | -74,000 | -35,000 | -81,000 | -99,000 | -105,000 |
| Investing Cash Flow | $-381,000 | $-333,000 | $-607,000 | $-238,000 | $-283,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 387,000 | 437,000 | 380,000 | 383,000 | 430,000 |
| Debt Issued | 684,000 | 778,000 | 1,401,000 | 10,000 | 1,543,000 |
| Debt Repayment | -536,000 | -841,000 | -962,000 | -45,000 | -1,372,000 |
| Common Stock Repurchased | -38,000 | N/A | -300,000 | N/A | -375,000 |
| Dividend Paid | -178,000 | -141,000 | -128,000 | -121,000 | -110,000 |
| Other Financing Activity | -507,000 | -570,000 | -449,000 | -514,000 | -414,000 |
| Financing Cash Flow | $-188,000 | $-337,000 | $-58,000 | $-287,000 | $-298,000 |
| Exchange Rate Effect | -12,000 | -3,000 | -21,000 | -10,000 | -2,000 |
| Beginning Cash Position | 205,000 | 270,000 | 426,000 | 323,000 | 442,000 |
| End Cash Position | 188,000 | 205,000 | 270,000 | 426,000 | 323,000 |
| Net Cash Flow | $-17,000 | $-65,000 | $-156,000 | $103,000 | $-119,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 564,000 | 608,000 | 530,000 | 638,000 | 464,000 |
| Capital Expenditure | -165,000 | -169,000 | -138,000 | -145,000 | -172,000 |
| Free Cash Flow | 399,000 | 439,000 | 392,000 | 493,000 | 292,000 |